Literature DB >> 2545728

Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism.

E Dejana1, M G Lampugnani, M Giorgi, M Gaboli, A B Federici, Z M Ruggeri, P C Marchisio.   

Abstract

Von Willebrand factor (vWF) is a constitutive and specific component of endothelial cell (EC) matrix. In this paper we show that, in vitro, vWF can induce EC adhesion and promote organization of microfilaments and adhesion plaques. In contrast, human vascular smooth muscle cells and MG63 osteosarcoma cells did not adhere and spread on vWF. Using antibodies to the beta chains of fibronectin (beta 1) and vitronectin (beta 3) receptors it was found that ECs adherent to vWF show clustering of both receptors. The beta 1 receptor antibodies are arranged along stress fibers at sites of extracellular matrix contact while the beta 3 receptor antibodies were sharply confined at adhesion plaques. ECs release and organize endogenous fibronectin early during adhesion to vWF. Upon blocking protein synthesis and secretion, ECs can equally adhere and spread on vWF but, while the beta 3 receptors are regularly organized, the beta 1 receptors remain diffuse. This suggests that the organization of the beta 1 receptors depend on the release of fibronectin and/or other matrix proteins operated by the same cell. Antibodies to the beta 3 receptors fully block EC adhesion to vWF and detach ECs seeded on this substratum. In contrast, antibodies to the beta 1 receptors are poorly active. Overall these results fit with an accessory role of beta 1 receptors and indicate a leading role for the beta 3 receptors in EC interaction with vWF. To identify the EC binding domain on vWF we used monoclonal antibodies produced against a peptide representing the residues Glu1737-Ser1750 of the mature vWF and thought to be important in mediating its binding to the platelet receptor glycoprotein IIb-IIIa. We found that the antibody that recognizes the residues 1,744-1,746, containing the Arg-Gly-Asp sequence, completely inhibit EC adhesion to vWF whereas a second antibody recognizing the adjacent residues 1,740-1,742 (Arg-Gly-Asp-free) is inactive. Both antibodies do not interfere with EC adhesion to vitronectin. This defines the molecular domain on vWF that is specifically recognized by ECs and reaffirms the direct role of the Arg-Gly-Asp sequence as the integrin receptor recognition site also in the vWF molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545728      PMCID: PMC2115492          DOI: 10.1083/jcb.109.1.367

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  39 in total

1.  The purification of human fibrinogen.

Authors:  R A KEKWICK; M E MACKAY; M H NANCE; B R RECORD
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

2.  Monovalent ionophores inhibit secretion of procollagen and fibronectin from cultured human fibroblasts.

Authors:  N Uchida; H Smilowitz; M L Tanzer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

3.  Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium.

Authors:  K S Sakariassen; P A Bolhuis; J J Sixma
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

4.  Proteolytic processing of presecretory proteins is required for development of biological activities in pancreatic exocrine proteins.

Authors:  G Scheele; R Jacoby
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

5.  Evidence that vascular endothelial cells can induce the retraction of fibrin clots.

Authors:  B Barbieri; G Balconi; E Dejana; M B Donati
Journal:  Proc Soc Exp Biol Med       Date:  1981-11

6.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

7.  Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.

Authors:  T Fujimoto; S Ohara; J Hawiger
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

8.  The binding of fibrinogen to its platelet receptor.

Authors:  G A Marguerie; N Ardaillou; G Cherel; E F Plow
Journal:  J Biol Chem       Date:  1982-10-25       Impact factor: 5.157

9.  Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.

Authors:  L De Marco; S S Shapiro
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

10.  Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor.

Authors:  H R Baumgartner; T B Tschopp; D Meyer
Journal:  Br J Haematol       Date:  1980-01       Impact factor: 6.998

View more
  21 in total

Review 1.  Tissue engineering in the vascular graft.

Authors:  S P Massia; J A Hubbell
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.

Authors:  L A Bunce; L A Sporn; C W Francis
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

3.  Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane.

Authors:  Lea Scheppke; Eric A Murphy; Alessandro Zarpellon; Jennifer J Hofmann; Alona Merkulova; David J Shields; Sara M Weis; Tatiana V Byzova; Zaverio M Ruggeri; M Luisa Iruela-Arispe; David A Cheresh
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

4.  Differing microvasculature in the two major types of gastric carcinoma: a conventional, ultrastructural and ultrastructural immunolocalization study of von Willebrand factor.

Authors:  H Ohtani; H Nagura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide.

Authors:  R F Nicosia; E Bonanno
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

Review 6.  Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells.

Authors:  P N Belloni; R J Tressler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

Review 7.  Adhesion molecules and their role in cancer metastasis.

Authors:  R M Lafrenie; M R Buchanan; F W Orr
Journal:  Cell Biophys       Date:  1993 Aug-Dec

8.  Angiogenic and cell proliferating action of the natural diarylnonanoids, malabaricone B and malabaricone C during healing of indomethacin-induced gastric ulceration.

Authors:  Debashish Banerjee; Biswanath Maity; Atmaram H Bandivdeker; Sandip K Bandyopadhyay; Subrata Chattopadhyay
Journal:  Pharm Res       Date:  2007-12-11       Impact factor: 4.200

9.  Role of vitronectin in embryonic rat endocardial cell migration in vitro.

Authors:  H Sumida; H Nakamura; M Yasuda
Journal:  Cell Tissue Res       Date:  1992-04       Impact factor: 5.249

10.  Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice.

Authors:  Debashish Banerjee; Sayanti Bhattacharya; Sandip K Bandyopadhyay; Subrata Chattopadhyay
Journal:  Dig Dis Sci       Date:  2008-04-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.